| Financial Year |
March 31 2023 |
| Monetary Funds |
274,631,057.71 |
| Held-for-trading Financial Assets |
54,934,292.96 |
| Notes Receivable |
-- |
| Accounts Receivable |
72,278,679.66 |
| Advances to Suppliers |
101,972,631.04 |
| Other Receivables |
19,272,445.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
268,681,201.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
35,539,566.27 |
| Total Current Assets |
827,309,874.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
238,938,238.37 |
| Investment Properties |
-- |
| Fixed Assetes |
30,026,409.30 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
147,708,145.75 |
| R&D expenses |
18,627,969.86 |
| Goodwill |
281,176,707.89 |
| Long-Term Deferred and Prepaid Expenses |
95,599,257.03 |
| Deferred Income Tax Assets |
24,027,448.98 |
| Other Non-Current Assets |
35,929,779.10 |
| Sub-Total of Non-Current Assets |
1,164,459,374.81 |
| Total Assets |
1,991,769,249.67 |
| Short-Term Loans |
105,276,254.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
105,955,757.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,729,266.48 |
| Taxes Payable |
3,638,329.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
17,603,914.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,897,974.13 |
| Other Current Liabilities |
4,363,641.15 |
| Sub-Total of Current Liabilities |
335,111,949.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,471,041.85 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,688,564.28 |
| Total Liabilities |
366,800,513.29 |
| Paid-In Capital(Or Share Stock) |
604,795,417.00 |
| Capital Surplus |
2,203,474,110.03 |
| Surplus Reserve |
27,337,488.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-959,159,189.72 |
| Minority Stockholder's Interest |
-188,738,677.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,813,707,413.38 |
| Owner's Equity（Stockholder's Equity） |
1,624,968,736.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,991,769,249.67 |
